The Cannabis ETF (THCX)
ARCA ARCA Primary 
Maximizing Returns: The Top Cannabis REITs for Long-Term Investment Strategies
Ancillary cannabis stocks, particularly Cannabis REITs, are gaining attention due to their potential for steady dividends. Cannabis REITs invest in real estate properties leased to cannabis operators. This provides a unique opportunity for investors to earn income. The US cannabis industry is projected to grow at a compound annual growth rate (CAGR) of over 20% through 2030. This growth is driven by increasing legalization and market expansion. Recent headlines have focused on potential federal legalization, which could significantly boost the industry. As the market evolves, ancillary stocks like REITs are positioned to benefit from the industry's expansion.
Best Ancillary Cannabis Stocks to Keep an Eye on This September
The US cannabis industry has grown significantly, with projections estimating the market could reach $40 billion by 2025. As more states legalize cannabis, ancillary companies supporting the industry have become critical players. These companies provide essential products and services, such as hydroponic equipment and cultivation supplies. Recent headlines highlight the push for federal legalization as Congress considers new bills aimed at decriminalizing cannabis. Investors are closely watching this space as legalization could open new revenue streams. Given this promising outlook, ancillary cannabis stocks have become attractive for those seeking to capitalize on the industry's growth.
Cannabis Stocks Get Boost as Trump Backs Easing Restrictions
Shares of Canopy Growth (CGC), Tilray Brands (TLRY), and other cannabis providers surged in intraday trading Monday after former President Donald Trump signaled his support for reducing restrictions on marijuana use.
Is Cresco Labs An Overlooked Cannabis Stock? Market Potential In Ohio, Florida & Pennsylvania Promise Opportunity
Despite trading at a discount to its peers, this company is well-positioned to benefit from various dynamics, presenting a potential opportunity for investors. A Monday morning note from Zuanic & Associates, rates Cresco Labs CRLBF as “Overweight” among the top five multi-state operators (MSOs) in the U.S.
Cannabis stocks rally as Trump backs rescheduling, Florida legalization
Cannabis shares gained traction during Monday's session after Donald Trump endorsed the federal rescheduling of marijuana to allow research into its medical benefits. In a post on his social media platform Truth Social, the Republic presidential candidate said his administration would pass “common sense laws,” specifically the SAFER Banking Act and rescheduling cannabis to the lower-risk Schedule 3 of the Controlled Substances Act.
Marijuana Stocks To Watch Today In The Cannabis Sector
Marijuana stock investors see the future of the cannabis industry to have greater success. Beyond regulatory and federal reform there has been lots of growth as a sector and money made. Currently, most legal operators in the USA generate billions in quarterly revenue. This shows that there can be a space for a cannabis market to exist among other legitimate businesses.
September 2024 Watchlist: Leading Cannabis REITs for Investment
The US cannabis industry continues to grow, reaching $32 billion in annual sales in 2023. Experts predict this number will exceed $50 billion by 2028 as more states legalize cannabis. This rapid growth provides ample opportunities for cannabis REITs, which lease properties to licensed operators. Recent headlines, such as Congress debating federal legalization, add further momentum to the market. As legalization efforts progress, REITs are expected to see increased demand for cultivation and retail spaces. Investors looking for steady returns should closely watch the top-performing REITs.
Best Canadian Cannabis Stocks to Watch in September
Investors looking to capitalize on the growing cannabis market should watch top Canadian marijuana stocks this week. With the US cannabis industry projected to reach $41 billion by 2025, many Canadian companies are expanding their presence across the border. This expansion is driven by increasing legalization efforts and growing consumer demand. For example, recent news highlights the potential for federal legalization in the US, which could open up significant opportunities for Canadian companies. Investors should utilize technical analysis and proper risk management strategies to navigate this dynamic market. Analyzing price trends, volume, and support levels can provide valuable insights into potential stock movements.
Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan' issue
Alliance Global Partners Aaron Grey sees Donald Trump's weekend statement on cannabis as a step forward.
2 Marijuana Stocks To Buy If For New Cannabis Investors
Many marijuana stock investors are focused on the future as there is much in the works. For instance, with it being an election year we could see another moment of build-up for a major letdown. Yet even if presidential candidates do not do anything for legal cannabis speculation could still create momentum. As well there are more legal operators looking to show innovation. Plus continued growth as legal cannabis becomes viewed as a legitimate industry.
Top Ancillary Cannabis Stocks to Keep on Your Radar in September
As the cannabis industry in the United States continues to grow, ancillary marijuana stocks are attracting significant attention from investors. These companies provide essential services and products that support the broader cannabis market, making them integral to the industry's success. Currently, the US cannabis market is valued at over $30 billion, with projections indicating it could reach $50 billion by 2026. This rapid growth and increasing legalization efforts nationwide make ancillary cannabis stocks an intriguing investment opportunity. Recently, headlines have highlighted ongoing discussions about federal legalization, which could further boost the market. However, navigating this sector requires a careful approach, particularly given its volatility.
Cannabis Stocks Slide as DEA Sets Post-Election Marijuana Hearing in December
Cannabis stocks slumped Tuesday after the Drug Enforcement Administration (DEA) announced a hearing that could reclassify marijuana as a less harmful, Schedule III drug won't come until Dec. 2—after the 2024 presidential election.
